BioValley Business Angels Club (BioBAC) logo

BioValley Business Angels Club (BioBAC)

Description

BioBAC is a platform which matches its members with life sciences start-up projects to ensure risk capital and other needed resources.

Investor Profile

BioValley Business Angels Club (BioBAC) has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (25%)
  • Series B (25%)
  • Series A (25%)
  • Series C (25%)

Country Focus

  • Switzerland (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Medical Device
  • Dental
  • Health Care
  • Manufacturing
  • Navigation
  • Robotics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BioValley Business Angels Club (BioBAC) frequently co-invest with?

SN
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
Zürcher Kantonal Bank
Europe, Zurich, Switzerland, Zürich
Co-Investments: 3
GoBeyond
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Aargauische Kantonalbank
Europe, Aargau, Switzerland, Aarau
Co-Investments: 1
AV
Europe, Basel-Landschaft, Switzerland, Allschwil
Co-Investments: 1
SHS Capital
Europe, Baden-Wurttemberg, Germany, Tübingen
Co-Investments: 1
EB
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
TR Invest
Europe, Fribourg, Switzerland, Tafers
Co-Investments: 1

What are some of recent deals done by BioValley Business Angels Club (BioBAC)?

AOT - Advanced Osteotomy Tools

Basel, Basel-Stadt, Switzerland

Advanced Osteotomy Tools engages in the development of medical devices for advanced osteotomy.

ManufacturingMedical DeviceNavigationPharmaceuticalRobotics
Series CJun 7, 2016
Amount Raised: $11,373,094
Credentis

Windisch, Aargau, Switzerland

Credentis develops and commercializes an enamel and dentin demineralization system to treat caries lesions and related illnesses.

BiotechnologyDentalMedicalMedical Device
Series BMar 11, 2013
Amount Raised: $1,675,826
ProteoMediX

Schlieren, Zurich, Switzerland

ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer.

BiotechnologyHealth CareMedical
Series AJan 12, 2012
Amount Raised: $2,746,321
BioVersys

Basel, Basel-Stadt, Switzerland

BioVersys is a privately held Swiss biopharmaceutical company.

BiotechnologyPharmaceutical
SeedMar 31, 2011
Amount Raised: $2,729,207